Unnati Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Mumbai, Maharashtra, India, established in 2003.
2003 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Unnati Pharmaceuticals Private Limited

Unnati Pharmaceuticals Private Limited, a active private limited company, was established on 24 June 2003 in Mumbai, Maharashtra, India. Engaging in medicinal chemical & botanical products within the manufacturing sector, it holds CIN: U24231MH2003PTC428884. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.05 M and a paid-up capital of ₹0.90 M.

It upholds a compliant status. Its leadership includes Naishil Hetal Mehta (Director), Hetal Bhupatrai Mehta (Director). Past directors included Kaushik Kantilal Parekh, Kiran Chandrakant Sanghavi, Naishil Hetal Mehta. It holds ₹12.88 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Unit No 301/401 Sai Chambers Chs Ltd Road No 3, Near Santacruz Bus Depot, Mumbai, Maharashtra, 400055.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231MH2003PTC428884

  • Registration Number

    428884

  • Incorporation Date

    24 June 2003

  • Authorized Capital

    ₹1.05 M

  • Paid-Up Capital

    ₹0.90 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.05 M
  • Paid Up Capital ₹ 0.90 M
  • Company Age 22 Year, 7 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 12.88 Cr
  • Revenue Growth **** -2.93%
  • Profit Growth **** -46.70%
  • Ebitda **** -26.81%
  • Net Worth 7.90%
  • Total Assets **** 3.65%
Company report

Unnati Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Unnati Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Unnati Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Naishil Hetal Mehta Director 21 Dec 2016 Current
Hetal Bhupatrai Mehta Director 30 Jun 2010 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 31 May 2009 Past
Pramod Abcsdd Director 30 Nov 2011 Past
Pramod Abcsdd Additional Director 30 Sep 2017 Past
Pramod Abcsdd Additional Director 21 Dec 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Unnati Pharmaceuticals.

Unnati Pharmacuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 2.93% decrease. The company also saw a substantial fall in profitability, with a 46.7% decrease in profit. The company's net worth moved up by a moderate rise of 7.9%.

Unnati Pharmaceuticals revenue growth over time
Unnati Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -2.93%
*******
*******
*******
*******
Revenue from Operations
*******
 -2.91%
*******
*******
*******
*******
Total Assets
*******
 3.65%
*******
*******
*******
*******
Profit or Loss
*******
 -46.70%
*******
*******
*******
*******
Net Worth
*******
 7.90%
*******
*******
*******
*******
EBITDA
*******
 -26.81%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Unnati Pharmaceuticals?

In 2023, Unnati Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹128,834,500.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 12.88 Cr
Latest Charge Details
Date Lender Amount Status
04 Mar 2022 Hdfc Bank Limited ₹1.33 M Open
12 Mar 2018 Hdfc Bank Limited ₹5.00 Cr Open
28 Feb 2008 Hdfc Bank Limited ₹7.75 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Unnati Pharmaceuticals?

Unlock and access historical data on people associated with Unnati Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Unnati Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unnati Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Unnati Pharmaceuticals
Recent Activity within the Organization
  • Charges

    A charge with Hdfc Bank Limited of Rs. 77.50 M registered on 28 Feb 2008 with Charge ID 10114657 was modified on 21 Mar 2025. was recorded as a recent event.

  • Annual General Meeting

    The activity Unnati Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Unnati Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 1.33 M with Charge ID 100558502 was registered on 04 Mar 2022. was recorded as a recent event.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 50.00 M with Charge ID 100193433 was registered on 12 Mar 2018. was documented.

  • Director Appointment

    The activity Naishil Hetal Mehta was appointed as a Director was appointed as a Director on 21 Dec 2016 & has been associated with this company since 9 years 1 month . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Unnati Pharmaceuticals Private Limited?

The CIN of Unnati Pharmaceuticals Private Limited is U24231MH2003PTC428884.

Where is Unnati Pharmaceuticals Private Limited headquartered?

Unnati Pharmaceuticals Private Limited is headquartered at Unit No 301/401 Sai Chambers Chs Ltd Road No 3, Near Santacruz Bus Depot, Mumbai, Maharashtra, 400055.

When was Unnati Pharmaceuticals Private Limited incorporated?

Unnati Pharmaceuticals Private Limited was incorporated on 24 June 2003.

Who are the current directors of Unnati Pharmaceuticals Private Limited?

The current directors of Unnati Pharmaceuticals Private Limited are

What is the primary industry of Unnati Pharmaceuticals Private Limited?

The primary industry of Unnati Pharmaceuticals Private Limited is Manufacturing.

Is Unnati Pharmaceuticals Private Limited a listed company?

Unnati Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Unnati Pharmaceuticals Private Limited?

The authorized capital of Unnati Pharmaceuticals Private Limited is ₹1.05 M, and the paid-up capital is ₹0.90 M.

What is the compliance status of Unnati Pharmaceuticals Private Limited?

The compliance status of Unnati Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available